Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report

详细信息    查看全文

• 作者：Yiming Tian ; Rui Wang ; Lianyuan Liu ; Chunming Ma ; Qiang Lu…
• 关键词：Zoledronic acid ; Alendronate ; Bisphosphonate ; Uveitis ; Osteoporosis ; Macular edema ; Acute phase reaction
• 刊名：BMC Musculoskeletal Disorders
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：17
• 期：1
• 全文大小：852 KB
• 参考文献：1.Bobba RS, Beattie K, Parkinson B, Kumbhare D, Adachi JD. Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease. Drug Saf. 2006;29(12):1133–52.CrossRef PubMed
  2.French DD, Margo CE. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina. 2008;28(6):889–93.CrossRef PubMed
  3.Patel DV, Bolland M, Nisa Z, Al-Abuwsi F, Singh M, Horne A, et al. Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial. Osteoporos Int. 2015;26(2):499–5.CrossRef PubMed
  4.Patel DV, Horne A, House M, Reid IR, McGhee CN. The incidence of acute anterior uveitis after intravenous zoledronate. Ophthalmology. 2013;120(4):773–6.CrossRef PubMed
  5.Freitas-Neto CA, de Oliveira Fagundes WB, Ribeiro Jr M, Pacheco KD, Freitas LG, Avila MP. Unilateral Uveitis with Vitreous Haze Following Zoledronic Acid Therapy for Osteoporosis. Semin Ophthalmol. 2013. doi:10.​1007/​s801090000086 .PubMed
  6.Boni C, Kordic H, Chaloupka K. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review. Klin Monbl Augenheilkd. 2013;230(4):367–9.CrossRef PubMed
  7.Albani-Campanario M, Buendia-Diaz G, Flores-Islas Mde L, Maquita-Nakano C, Ochoa-Cervantes J. Zoledronic acid-based uveitis: a case report and a bibliography review. Ginecol Obstet Mex. 2012;80(5):355–9.PubMed
  8.Peterson JD, Bedrossian Jr EH. Bisphosphonate-associated orbital inflammation--a case report and review. Orbit. 2012;31(2):119–23.CrossRef PubMed
  9.Banal F, Briot K, Ayoub G, Dougados M, Roux C. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer. J Rheumatol. 2008;35(12):2458–9.CrossRef PubMed
  10.Kilickap S, Ozdamar Y, Altundag MK, Dizdar O. A case report: zoledronic acid-induced anterior uveitis. Med Oncol. 2008;25(2):238–40.CrossRef PubMed
  11.Moore MM, Beith JM. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer. Med J Aust. 2008;188(6):370–1.PubMed
  12.Woo TC, Joseph DJ, Wilkinson R. Serious ocular complications of zoledronate. Clin Oncol (R Coll Radiol). 2006;18(7):545–6.CrossRef
  13.El Saghir NS, Otrock ZK, Bleik JH. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer. BMC Cancer. 2005;5:156.PubMedCentral CrossRef PubMed
  14.Durnian JM, Olujohungbe A, Kyle G. Bilateral acute uveitis and conjunctivitis after zoledronic acid therapy. Eye (Lond). 2005;19(2):221–2.CrossRef
  15.Ryan PJ, Sampath R. Idiopathic orbital inflammation following intravenous pamidronate. Rheumatology (Oxford). 2001;40(8):956–7.CrossRef
  16.Subramanian PS, Kerrison JB, Calvert PC, Miller NR. Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer. Arch Ophthalmol. 2003;121(9):1335–6.CrossRef PubMed
  17.Mbekeani JN, Slamovits TL, Schwartz BH, Sauer HL. Ocular inflammation associated with alendronate therapy. Arch Ophthalmol. 1999;117(6):837–8.PubMed
  18.Fietta P, Manganelli P, Lodigiani L. Clodronate induced uveitis. Ann Rheum Dis. 2003;62(4):378–1.PubMedCentral CrossRef PubMed
  19.Dalle Carbonare L, Zanatta M, Gasparetto A, Valenti MT. Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management. Drug Healthc Patient Saf. 2010;2:121–37.PubMedCentral CrossRef PubMed
  20.Patel DV, Horne A, Mihov B, Stewart A, Reid IR, McGhee CN. The Effects of Re-challenge in Patients with a History of Acute Anterior Uveitis Following Intravenous Zoledronate. Calcif Tissue Int. 2015;97(1):58–61.CrossRef PubMed
  21.Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM. Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab. 2010;95(9):4380–7.CrossRef PubMed
  22.Cavallasca JA, Reyt C. [Acute anterior uveitis associated with the use zoledronic acid]. Medicina (B Aires). 2014;74(5):428–9.
  23.Belliveau MJ, Almeida DR, Urton TE. Acute anterior uveitis following zoledronic acid infusion for osteoporosis. Can J Ophthalmol. 2012;47(5):e22–3.CrossRef PubMed
  24.Rathnam KK, Sagar TG, Cyriac S. Acute uveitis following zoledronic acid infusion. Oman J Ophthalmol. 2009;2(2):102–3.PubMedCentral CrossRef PubMed
  25.Colucci A, Modorati G, Miserocchi E, Di Matteo F, Rama P. Anterior uveitis complicating zoledronic acid infusion. Ocul Immunol Inflamm. 2009;17(4):267–8.CrossRef PubMed
  26.Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Erratum to: Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2015;26(7):2045–7.doi: 10.​1007/​s00198-015-3037-x .PubMedCentral CrossRef PubMed
  27.Yang EB, Birkholz ES, Lee AG. Another case of bisphosphonate-induced orbital inflammation. J Neuroophthalmol. 2010;30(1):94–5.CrossRef PubMed
  28.Etminan M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ. 2012;184(8):E431–4.PubMedCentral CrossRef PubMed
  29.Hewitt RE, Lissina A, Green AE, Slay ES, Price DA, Sewell AK. The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins. Clin Exp Immunol. 2005;139(1):101–11.PubMedCentral CrossRef PubMed
  
• 作者单位：Yiming Tian (1)
  Rui Wang (1)
  Lianyuan Liu (2)
  Chunming Ma (1)
  Qiang Lu (1)
  Fuzai Yin (1)
  
  1. Department of Endocrinology, The First Hospital of Qinhuangdao, Hebei, China
  2. Liaison Office, the First Hospital of Qinhuangdao, Hebei, China
  
• 刊物主题：Orthopedics; Rehabilitation; Rheumatology; Sports Medicine; Internal Medicine;
• 出版者：BioMed Central
• ISSN：1471-2474

文摘

Background Zoledronic acid-induced uveitis (ZAIU) is rare but severe, and has been recently considered part of an acute phase reaction. Only 15 cases have been reported since 2005. Here we describe a case with macular edema, which is the first reported case observed after long-term alendronate tolerance.